annual EBITDA:
$9.21M+$13.10M(+336.52%)Summary
- As of today (May 29, 2025), CDXC annual EBITDA is $9.21 million, with the most recent change of +$13.10 million (+336.52%) on December 31, 2024.
- During the last 3 years, CDXC annual EBITDA has risen by +$34.66 million (+136.19%).
- CDXC annual EBITDA is now at all-time high.
Performance
CDXC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$5.14M-$2.33M(-31.18%)Summary
- As of today (May 29, 2025), CDXC quarterly EBITDA is $5.14 million, with the most recent change of -$2.33 million (-31.18%) on March 31, 2025.
- Over the past year, CDXC quarterly EBITDA has increased by +$5.48 million (+1607.33%).
- CDXC quarterly EBITDA is now -31.18% below its all-time high of $7.47 million, reached on December 31, 2024.
Performance
CDXC quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$14.69M+$5.48M(+59.51%)Summary
- As of today (May 29, 2025), CDXC TTM EBITDA is $14.69 million, with the most recent change of +$5.48 million (+59.51%) on March 31, 2025.
- Over the past year, CDXC TTM EBITDA has increased by +$17.40 million (+642.70%).
- CDXC TTM EBITDA is now at all-time high.
Performance
CDXC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDXC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +336.5% | +1607.3% | +642.7% |
| 3 y3 years | +136.2% | +171.6% | +157.2% |
| 5 y5 years | +130.9% | +193.1% | +153.8% |
CDXC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +136.2% | -31.2% | +171.6% | at high | +155.4% |
| 5 y | 5-year | at high | +130.9% | -31.2% | +161.0% | at high | +153.8% |
| alltime | all time | at high | +128.5% | -31.2% | +159.7% | at high | +144.6% |
CDXC EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $5.14M(-31.2%) | $14.69M(+59.5%) |
| Dec 2024 | $9.21M(-336.5%) | $7.47M(+279.5%) | $9.21M(+373.3%) |
| Sep 2024 | - | $1.97M(+1626.3%) | $1.95M(-369.9%) |
| Jun 2024 | - | $114.00K(-133.4%) | -$721.00K(-73.4%) |
| Mar 2024 | - | -$341.00K(-266.3%) | -$2.71M(-30.5%) |
| Dec 2023 | -$3.89M(-76.7%) | $205.00K(-129.3%) | -$3.89M(-23.5%) |
| Sep 2023 | - | -$699.00K(-62.7%) | -$5.09M(-27.4%) |
| Jun 2023 | - | -$1.87M(+22.5%) | -$7.00M(-36.8%) |
| Mar 2023 | - | -$1.53M(+54.5%) | -$11.09M(-33.8%) |
| Dec 2022 | -$16.74M(-34.2%) | -$989.00K(-62.2%) | -$16.74M(-19.0%) |
| Sep 2022 | - | -$2.62M(-56.1%) | -$20.68M(-21.9%) |
| Jun 2022 | - | -$5.96M(-17.1%) | -$26.49M(+3.2%) |
| Mar 2022 | - | -$7.18M(+45.8%) | -$25.68M(+0.9%) |
| Dec 2021 | -$25.45M(+38.7%) | -$4.93M(-41.5%) | -$25.45M(-2.9%) |
| Sep 2021 | - | -$8.43M(+63.9%) | -$26.20M(+21.3%) |
| Jun 2021 | - | -$5.14M(-26.1%) | -$21.60M(+9.2%) |
| Mar 2021 | - | -$6.96M(+22.3%) | -$19.77M(+7.8%) |
| Dec 2020 | -$18.34M(-38.4%) | -$5.69M(+48.9%) | -$18.34M(-13.3%) |
| Sep 2020 | - | -$3.82M(+15.2%) | -$21.16M(-11.2%) |
| Jun 2020 | - | -$3.31M(-40.0%) | -$23.82M(-12.7%) |
| Mar 2020 | - | -$5.52M(-35.1%) | -$27.30M(-8.3%) |
| Dec 2019 | -$29.78M(-7.9%) | -$8.50M(+31.1%) | -$29.78M(+1.7%) |
| Sep 2019 | - | -$6.49M(-4.4%) | -$29.28M(-6.0%) |
| Jun 2019 | - | -$6.79M(-15.2%) | -$31.16M(-2.9%) |
| Mar 2019 | - | -$8.00M(-0.1%) | -$32.11M(-0.7%) |
| Dec 2018 | -$32.33M(+106.4%) | -$8.01M(-4.3%) | -$32.33M(-1.8%) |
| Sep 2018 | - | -$8.37M(+8.2%) | -$32.93M(+19.5%) |
| Jun 2018 | - | -$7.73M(-5.9%) | -$27.55M(+23.7%) |
| Mar 2018 | - | -$8.22M(-4.5%) | -$22.26M(+42.1%) |
| Dec 2017 | -$15.66M(+530.0%) | -$8.61M(+188.2%) | -$15.66M(+72.0%) |
| Sep 2017 | - | -$2.99M(+21.9%) | -$9.10M(+31.1%) |
| Jun 2017 | - | -$2.45M(+51.2%) | -$6.94M(+72.8%) |
| Mar 2017 | - | -$1.62M(-21.0%) | -$4.02M(+117.2%) |
| Dec 2016 | -$2.49M | -$2.05M(+148.7%) | -$1.85M(+113.3%) |
| Sep 2016 | - | -$824.40K(-273.5%) | -$867.50K(-495.8%) |
| Jun 2016 | - | $475.10K(-13.4%) | $219.20K(-161.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $548.70K(-151.4%) | -$358.50K(-79.3%) |
| Dec 2015 | -$1.74M(-65.1%) | -$1.07M(-506.7%) | -$1.74M(+2.1%) |
| Sep 2015 | - | $262.30K(-355.7%) | -$1.70M(-33.2%) |
| Jun 2015 | - | -$102.60K(-87.6%) | -$2.55M(-36.7%) |
| Mar 2015 | - | -$828.30K(-19.7%) | -$4.02M(-19.1%) |
| Dec 2014 | -$4.97M(+20.8%) | -$1.03M(+76.8%) | -$4.97M(+8.3%) |
| Sep 2014 | - | -$583.20K(-63.0%) | -$4.59M(-11.5%) |
| Jun 2014 | - | -$1.58M(-11.4%) | -$5.19M(+13.7%) |
| Mar 2014 | - | -$1.78M(+174.1%) | -$4.56M(+10.9%) |
| Dec 2013 | -$4.12M(-63.5%) | -$649.30K(-45.1%) | -$4.12M(-18.9%) |
| Sep 2013 | - | -$1.18M(+24.2%) | -$5.07M(-4.9%) |
| Jun 2013 | - | -$952.00K(-28.5%) | -$5.34M(-35.6%) |
| Mar 2013 | - | -$1.33M(-17.1%) | -$8.29M(-26.6%) |
| Dec 2012 | -$11.29M(+51.3%) | -$1.61M(+11.1%) | -$11.29M(-6.5%) |
| Sep 2012 | - | -$1.45M(-62.9%) | -$12.07M(-6.6%) |
| Jun 2012 | - | -$3.90M(-10.0%) | -$12.92M(+20.2%) |
| Mar 2012 | - | -$4.33M(+81.6%) | -$10.75M(+44.0%) |
| Dec 2011 | -$7.46M(+358.0%) | -$2.39M(+3.9%) | -$7.46M(+27.2%) |
| Sep 2011 | - | -$2.30M(+32.6%) | -$5.87M(+35.1%) |
| Jun 2011 | - | -$1.73M(+65.4%) | -$4.34M(+54.6%) |
| Mar 2011 | - | -$1.05M(+32.6%) | -$2.81M(+72.4%) |
| Dec 2010 | -$1.63M(+227.1%) | -$790.00K(+2.0%) | -$1.63M(+91.2%) |
| Sep 2010 | - | -$774.20K(+292.4%) | -$852.40K(+450.6%) |
| Jun 2010 | - | -$197.30K(-249.7%) | -$154.80K(+6.7%) |
| Mar 2010 | - | $131.80K(-1137.8%) | -$145.10K(-70.9%) |
| Dec 2009 | -$498.20K(-70.5%) | -$12.70K(-83.4%) | -$498.20K(-50.6%) |
| Sep 2009 | - | -$76.60K(-59.2%) | -$1.01M(-34.3%) |
| Jun 2009 | - | -$187.60K(-15.2%) | -$1.54M(-22.2%) |
| Mar 2009 | - | -$221.30K(-57.7%) | -$1.97M(+12.4%) |
| Dec 2008 | -$1.69M(+4295.1%) | -$523.30K(-13.3%) | -$1.76M(+42.5%) |
| Sep 2008 | - | -$603.40K(-3.6%) | -$1.23M(+93.5%) |
| Jun 2008 | - | -$626.00K(>+9900.0%) | -$636.70K(+4581.6%) |
| Feb 2008 | - | -$2900.00(-17.1%) | -$13.60K(-41.6%) |
| Nov 2007 | -$38.40K | -$3500.00(-18.6%) | -$23.30K(+17.7%) |
| Aug 2007 | - | -$4300.00(+48.3%) | -$19.80K(+27.7%) |
| May 2007 | - | -$2900.00(-77.0%) | -$15.50K(+23.0%) |
| Feb 2007 | - | -$12.60K | -$12.60K |
FAQ
- What is ChromaDex annual EBITDA?
- What is the all time high annual EBITDA for ChromaDex?
- What is ChromaDex annual EBITDA year-on-year change?
- What is ChromaDex quarterly EBITDA?
- What is the all time high quarterly EBITDA for ChromaDex?
- What is ChromaDex quarterly EBITDA year-on-year change?
- What is ChromaDex TTM EBITDA?
- What is the all time high TTM EBITDA for ChromaDex?
- What is ChromaDex TTM EBITDA year-on-year change?
What is ChromaDex annual EBITDA?
The current annual EBITDA of CDXC is $9.21M
What is the all time high annual EBITDA for ChromaDex?
ChromaDex all-time high annual EBITDA is $9.21M
What is ChromaDex annual EBITDA year-on-year change?
Over the past year, CDXC annual EBITDA has changed by +$13.10M (+336.52%)
What is ChromaDex quarterly EBITDA?
The current quarterly EBITDA of CDXC is $5.14M
What is the all time high quarterly EBITDA for ChromaDex?
ChromaDex all-time high quarterly EBITDA is $7.47M
What is ChromaDex quarterly EBITDA year-on-year change?
Over the past year, CDXC quarterly EBITDA has changed by +$5.48M (+1607.33%)
What is ChromaDex TTM EBITDA?
The current TTM EBITDA of CDXC is $14.69M
What is the all time high TTM EBITDA for ChromaDex?
ChromaDex all-time high TTM EBITDA is $14.69M
What is ChromaDex TTM EBITDA year-on-year change?
Over the past year, CDXC TTM EBITDA has changed by +$17.40M (+642.70%)